BioHarvest Sciences (BHST) Institutional Ownership $5.95 +0.64 (+12.05%) As of 02/21/2025 03:46 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for BioHarvest Sciences (NASDAQ:BHST)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$74.42KNumber ofInstitutional Sellers(last 12 months)0 Get BHST Insider Trade Alerts Want to know when executives and insiders are buying or selling BioHarvest Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BioHarvest Sciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025 TD Waterhouse Canada Inc.12,042$69K0.0%N/A0.073% (Data available from 1/1/2016 forward) BHST Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BHST shares? During the previous two years, the following institutional investors and hedge funds held shares of BioHarvest Sciences shares: TD Waterhouse Canada Inc. ($69K).Learn more on BHST's institutional investors. Which institutional investors have been buying BioHarvest Sciences stock? The following institutional investors have purchased BioHarvest Sciences stock in the last 24 months: TD Waterhouse Canada Inc. ($12.04K). How much institutional buying is happening at BioHarvest Sciences? Institutional investors have bought a total of 12,042 shares in the last 24 months. This purchase volume represents approximately $74.42K in transactions. Related Companies Esperion Therapeutics Institutional Ownership MBX Biosciences Institutional Ownership Terns Pharmaceuticals Institutional Ownership Foghorn Therapeutics Institutional Ownership Cryoport Institutional Ownership Annexon Institutional Ownership XOMA Institutional Ownership Corvus Pharmaceuticals Institutional Ownership Trevi Therapeutics Institutional Ownership COMPASS Pathways Institutional Ownership This page (NASDAQ:BHST) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioHarvest Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioHarvest Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
